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Abstract
We here propose the implementation of a simple and effective method to enhance the qual-
ity of basic and preclinical academic research: critical incident reporting (CIR). CIR has
become a standard in clinical medicine but to our knowledge has never been implemented
in the context of academic basic research. We provide a simple, free, open-source software
tool for implementing a CIR system in research groups, laboratories, or large institutions
(LabCIRS). LabCIRS was developed, tested, and implemented in our multidisciplinary and
multiprofessional neuroscience research department. It is accepted by all members of the
department, has led to the emergence of a mature error culture, and has made the labora-
tory a safer and more communicative environment. Initial concerns that implementation of
such a measure might lead to a “surveillance culture” that would stifle scientific creativity
turned out to be unfounded.
“Learning without thought is labour lost;
Thought without learning is perilous.”
—Confucius, 551–479 B.C. (cited after [1])
The realization that only a disappointingly small fraction of preclinical studies can be repli-
cated (“replication crisis” [2–4]) and the exceedingly low rate of preclinically very successful
treatment strategies that actually end up benefitting patients (“translational roadblock” [5])
have kindled a discussion questioning the robustness, rigor, and productiveness of current
experimental biomedical research. Numerous systematic reviews and meta-analyses in various
medical fields have exposed a prevalence of low internal validity of this type of research result-
ing from bias (such as selection, performance, outcome, and reporting bias) in addition to
exceedingly low sample sizes and consequently low statistical power. Alarmed by the waste of
resources and the harm to patients this might cause, researchers, journals, funders, and
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institutions have rushed to investigate, initiate, and implement measures for improving the
quality of preclinical research. Not surprisingly, many of these measures are inspired by clini-
cal medicine. Cognizant of deficits in study quality, clinical medicine went through a similar
process many decades ago. The subsequent implementation of measures such as blinding and
randomization, extensive and standardized record keeping, monitoring and auditing, preregis-
tration of studies, and quality management systems, to name but a few, greatly improved the
conduct and the validity of results in clinical research.
As a result of the current discussion relating to nonreproducibility of preclinical biomedical
research, a plethora of recommendations and potential remedies have been suggested [6–8].
These include a number of approaches to improve research quality in biomedical laboratories,
ranging from the authentication and standardization of biologicals and reagents [9] to the
implementation of full-blown quality management systems[10–13]. We here propose a simple
and effective method to enhance the quality of preclinical research: critical incident reporting
(CIR). CIR has become a standard in clinical medicine, and quality management systems rec-
ommend error management (e.g., International Organization for Standardization (ISO)
9001:2008; clause 8.3, “Control of Non-conforming Product,” [14]). To our knowledge, how-
ever, CIR has never been implemented in the context of academic basic research. Although
there are an increasing number of publications on preclinical quality management (e.g., [6,10–
13,15,16]), none of these articles mentions CIR or offers recommendations on how to learn
from errors and prevent them in the future. We here provide a simple, free, open-source soft-
ware tool written in the Python programming language to implement a simple CIR system in
research groups, laboratories, or institutions (LabCIRS, S1 Text).
Critical incident monitoring and reporting was initially described in 1954 [17] by Flanagan,
who adapted it from techniques developed to improve safety and performance among military
pilots in World War II. In clinical medicine, CIR was first introduced in anesthesiology in
1978 [18]. Today, reporting of critical incidents is an internationally recognized tool for
improving patient safety in clinical medicine. By introducing it into their legal regulations,
many countries have made CIR a mandatory element of hospital safety and quality manage-
ment procedures. The basic principle of CIR in clinical medicine is that safety can be improved
by learning from incidents that could have harmed or did harm patients, rather than by ignor-
ing such incidents. Adverse incidents are recorded anonymously, analyzed, discussed, and
communicated so that a recurrence can be prevented and harm avoided by learning from past
mistakes. This occurs primarily at the local (departmental or hospital) level, but databases
made available via the internet have facilitated the expansion of incident recording in clinical
medicine to the national and even international level.
The highly complex setting of a modern biomedical research laboratory with its high-tech
machinery, multiprofessional and often international staff with different levels of expertise,
complicated assays, and potentially harmful chemicals or biologicals is comparable to that of
aviation or human surgery and anesthesia. In preclinical research, critical incidents and errors
involve events that have the potential to negatively impact data integrity, experimental out-
comes, animal welfare, personnel safety, or viability of expensive reagents or machinery.
Errors, mishaps, and mistakes of variable severity frequently occur in this environment. While
certain areas like animal welfare or work with genetically modified organisms are strictly regu-
lated, no structured quality management systems are required in preclinical research, and
hence, no procedures for error management are mandated. Errors or critical incidents may
only be reported sporadically or erratically or might even be covered up for fear of negative
consequences [19].
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A Laboratory CIRS for Academic Biomedical Research
In clinical medicine, it is often necessary to clearly define and classify critical incidents. This is
not the case in preclinical research, in which there is no standard set of terms for recording
such incidents. However, the particularly open nature of the research process may lead to
unanticipated and even unorthodox events that deserve reporting. We set out to improve aca-
demic biomedical research by systematically learning from errors and mistakes. We estab-
lished a simple and scalable CIRS suitable for the preclinical biomedical research environment.
We then implemented and tested it in a typical, multidisciplinary academic laboratory. The
Department of Experimental Neurology, with approximately 100 students, researchers, and
technicians, carries out multiprofessional academic research in preclinical biomedicine with
such standard approaches and techniques as in vivo and in vitro modeling of disease, cell biol-
ogy, molecular biology, and biochemistry, as well as imaging (from multiphoton microscopy
to magnetic resonance imaging).
Box 1 lists the essential features we expect from a CIRS in basic and preclinical biomedicine.
The flow of information and resultant activities in LabCIRS is summarized in Fig 1:
LabCIRS can be accessed from every computer logged into the intranet of the department.
Incidents are reported anonymously, either in German or in English (see S1 and S2 Figs). A
demo version is accessible at http://labcirs.charite.de (sign in as “reporter”). The LabCIRS
“reviewer,” who could be a principal investigator (PI), a lab manager, or any other person with
the skills to initially assess reports, is alerted to incoming reports via email. The reviewer
assigns a risk category (low to high), determines responsibilities, initiates subsequent mea-
sures, and decides who is responsible for their implementation (see S3 Fig, sign in as
“reviewer” in the demo version). All reported incidents are analyzed in a regular monthly qual-
ity assurance conference. Depending on the nature of the reported incident, additional expert
Box 1. Features of a Laboratory CIR System for Experimental
Biomedicine
• Easy to set up, run, and administer
• Easy to use, accessible, intuitive, and unambiguous
• Should be scalable so that it works in small single-investigator groups as well as in a
large institute
• Allows anonymous reporting
• Allows free expression of “what actually happened”: the reporter’s own version of
events
• Reports must be handled in a nonpunitive manner
• The incidents reported can be regularly analyzed by experts
• Learning points from such analyses need to be fed back promptly to those who need to
know
• The reports are visible, and a clear path of action is communicated
• Feedback results in enhanced learning regarding the incident’s cause and systemic
changes that will prevent its recurrence
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members of the department may be invited to join the discussion. Time critical events are pro-
cessed immediately. Agreement is reached on specific prevention measures, responsibilities,
and an action plan. Relevant preventive measures are communicated to all members of the
department at the weekly morning conferences, and a monthly email to all staff members sum-
marizes events and countermeasures. These messages are accessible to everyone and are per-
manently archived in the LabCIRS. Errors and incidents are communicated anonymously,
unless the incident report includes the name of the reporting person and consent to reveal his
or her identity. Typically, the examples of incidents reported via the LabCIRS include injuries
when working with a sharp object, mistaken labeling of solutions and chemicals, mix-ups in
the randomization of experimental animals, and data loss due to instrument write failures.
Emergence of an Error Culture
Motivated by the exceedingly high attrition rate of bench to bedside translation in the stroke
research field, we began to establish a structured quality management (QM) system in our
experimental laboratories in 2012. The aim of our QM system is to implement auditable stan-
dards for the planning, realization, evaluation, and publication of our experimental studies
Fig 1. Cartoon of how LabCIRS helps to prevent further mishaps and fosters an error culture. “Error”: a
researcher mistook two faintly labeled reagents A and B, which ruined his experiment. “Reporting”: entry of
the incident into LabCIRS. “Assessment”: a group of experts (scientists and technicians) reviews the error and
takes preventive action by color labelling the reagents. “Feedback”: the errors as well as the measure to
prevent it in the future are communicated to the entire laboratory.
doi:10.1371/journal.pbio.2000705.g001
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and to safeguard compliance to guidelines (such as [20]) and institutional rules and regulations
of good scientific practice (GSP). We realized that for academic preclinical research there is a
paucity, if not to say a lack, of systematic approaches to improve and maintain quality. We had
to therefore design from scratch, implement, and refine effective and transparent procedures
for quality control in experimental neuroscience research in the university setting. To the best
of our knowledge, our QM system represents one of the first attempts to implement systematic
QM in academic preclinical research in Germany and possibly worldwide.
Since the ISO 9001:2008 norm [14], which we chose for our QM, requires the implementa-
tion of measures for identifying errors, we posted printed “error reporting sheets” in all our
laboratories. Disappointingly, only a few errors were reported via this mode. Through discus-
sions with scientists, students, and technicians, we realized that the main reason for the failure
of this error reporting system was that it did not safeguard anonymous reporting; potential
reporters feared punitive action. We therefore established the web-based system described
here, which includes additional benefits, such as accessibility on every computer in the lab,
uploading of photographs to describe the incident, automatic alerts of new reports to person-
nel responsible, and archiving.
As most academic research laboratories operate on a frugal budget, and funding organiza-
tions might be reluctant to cover costs beyond specific research projects, it is important to
know how resource intense the operation of LabCIRS is. In our department when an error is
reported, the reviewer categorizes the incident and decides whether acute measures are neces-
sary. If the reporter agreed to it, the report is communicated to the department. Error reports
are analyzed in detail at monthly meetings by a group consisting of various users and experts
(scientists, doctoral students, postdocs, and technicians) of the research groups. The group
also considers preventive measures against recurrence of the error. Relevant errors and coun-
termeasures are then communicated to all members of the department in a weekly joint lab
meeting. Additionally, all error reports are sent out monthly to all members of the department
via email. All in all, analyzing, discussing, and communicating one error report takes about 40
minutes.
LabCIRS was immediately accepted by all members of the laboratory. Since its inception,
approximately one to two incidents are reported per month (Fig 2). Interestingly, in the begin-
ning about half the reported incidents were not only anonymous but also strictly confidential
(i.e., the reporters ticked the option “I DO NOT agree that this report will be made public to
people outside the quality management team even after copyedit.”). For more than a year now,
all reporters tick the option “I agree that this report will be made public to people outside the
quality management team after copyedit.” We interpret this as a sign of trust and an indicator
of a mature error culture. Clearly, most members of the department have realized that while in
the complex setting of the biomedical laboratory, errors and incidents may occur, they can be
prevented in future through reflection on what happened and through the input of colleagues.
All reported errors have led to actions and preventive measures. These include modifications
of briefings, instructions, and responsibilities, changes in the way samples and chemicals are
labelled, and modifications of standard operating procedures, among many other provisions.
Anonymous reporting is a key feature of any CIRS. LabCIRS does not collect any personal
information from the reporter, as such information in a relatively small group of approxi-
mately 100 people could potentially reveal the identity of the reporter. In order to nevertheless
address the question of whether the use of LabCIRS differs between professions, we conducted
an anonymous online survey asking two questions: (1) Do you actively and/or passively use
LabCIRS (i.e., have you reported errors, or do you only read about errors in LabCIRS)? and (2)
What is your job profile or status within the lab? About half of the responding LabCIRS users
stated that they actively report incidents, while the other half uses the CIRS to stay informed
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about reported errors and countermeasures. The largest groups of the active reporters are
either technicians or lab managers, while students, postdocs, technicians, and group leaders
are represented almost equally among the passive users (Fig 3). It is not surprising that the
majority of active reporters belong to the groups which focus on practical laboratory work, but
our survey demonstrates that members of all professions use LabCIRS either actively or at least
passively. The only exception is undergraduate students, who do not work unsupervised in our
institute and are guided directly by members of other professions.
We are convinced that LabCIRS has clearly improved the quality of our work and made the
laboratory a safer and more communicative environment. Although desirable, it is unfortu-
nately hard to quantify the effectiveness of such a measure. The use of a CIRS cannot be tested
in a controlled experiment (one lab with and the other without CIRS). CIRS use is voluntary
and anonymous, and reported incidents do not necessarily represent all incidents that may
have happened. It should be noted that in many domains the use of CIRS is plausible and by
now the legal standard (aviation, nuclear power plants, etc.), but rarely, if at all, has its effi-
ciency been unequivocally proven in a controlled setting. Therefore, the efficacy of CIRS must
often remain anecdotal, much like the notion that the Chernobyl disaster could have been pre-
vented by critical incidence reporting [21].
Fig 2. Errors reported per quarter since system was initiated (I/2014) until June 2016. Grey: number of
errors reported publicly; orange: number of errors reported confidentially, i.e., without allowing the report to be
made public.
doi:10.1371/journal.pbio.2000705.g002
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Initial concerns by some members of the department that its implementation might lead to
a “surveillance culture” that would stifle creativity turned out to be totally unfounded. Never-
theless, it needs to be acknowledged that reporting mistakes, mishaps, and errors is a sensitive
issue in any work environment. Setting up a critical incidence reporting system must rely on
an intense communication among all members of the lab about its purpose and nonpunitive
nature. In addition, reporting of an incident is only the beginning of a sequence of events that
include the search for remedies and preventive measures. This only works in a collaborative
and quality-oriented environment. However, the administrative effort to maintain such a sys-
tem is minimal and likely compensated by the savings made through error prevention and
improved quality.
We highly recommend the establishment of a systematic way of learning from errors and
mistakes, whether in small single-investigator groups of a few researchers, students, and tech-
nicians, or in large research institutions with staffs of several hundred professionals. This prac-
tice will benefit the emergence of an error culture that will likely enhance the overall quality
and safety of research. The open-source LabCIRS we provide here can help to start this pro-
cess, but it needs to be stressed that the system lives with those who report, discuss, and dis-
seminate the incidents and countermeasures.
Supporting Information
S1 Fig. Screenshot of LabCIRS login.
(TIF)
S2 Fig. Screenshot of LabCIRS incident reporting page.
(TIF)
S3 Fig. Screenshot of LabCIRS incident reviewer login.
(TIF)
S1 Text. Demo version and source code.
(DOCX)
Fig 3. Results of an anonymous survey to explore which professions and status groups use LabCIRS
in an active or passive manner.
doi:10.1371/journal.pbio.2000705.g003
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